SymBiosis Capital Partners, LLC

Fundamental concentrated ★Signal healthcare specialist (100%) CIK 2006045
League rank
#938
in Fundamental concentrated · #7394 overall
Long book
$52.8M
Q1 2026
Positions
6
Top-10 weight
100%
concentration
Last quarter
-14.8%
SPY -4.4%
Turnover
58%
of book per quarter

Strategy in plain words

auto-generated from filings

SymBiosis Capital Partners, LLC is a concentrated fundamental stock-picker, specialised in healthcare (100% of the long book), running a $52.8M US long book across 6 positions.

The portfolio is extremely concentrated — the top 10 positions are almost the whole book. Turnover is high — positions rotate quickly, so individual names matter less than the process. Current anchor positions: EVOMMUNE INC, INVENTIVA SA - ADR, WAVE LIFE SCIENCES LTD, RANI THERAPEUTICS HOLDINGS-A, CLENE INC.

We rate its filings as signal-bearing: position changes reflect genuine views.

Sector allocation

Healthcare
100%

Long book by quarter

$109.5M
Q4 2025
$52.8M
Q1 2026

What does SymBiosis Capital own?

Q1 2026 13F
CompanySectorSharesValue% of bookChange
EVMN EVOMMUNE INCHealthcare1.3M$29.4M55.8%Held
WVE WAVE LIFE SCIENCES LTDHealthcare750.0K$5.4M10.3%New
RANI RANI THERAPEUTICS HOLDINGS-AHealthcare3.7M$2.7M5.1%-41.8%
CLNN CLENE INCHealthcare431.1K$2.1M4.0%-44.0%

13F filing history

PeriodFormFiledEntriesReported valueFlagsSource
Q1 202613F-HRMay 12, 20266$52.8M canonicalSEC ↗
Q4 202513F-HRFeb 12, 202611$109.5M canonicalSEC ↗

Similar funds

LILLY ENDOWMENT INCBAKER BROS. ADVISORS LPINVESTOR ABCarlyle Group Inc.GREENLEAF TRUSTAvoro Capital Advisors LLCRTW INVESTMENTS, LPRA CAPITAL MANAGEMENT, L.P.DEERFIELD MANAGEMENT COMPANY, L.P.Simplify Asset Management Inc.PERCEPTIVE ADVISORS LLCParadigm Biocapital Advisors LP